US Oncology Network Hereditary Genetics and Precision Medicine Conference 2025

Join Tempus and Ambry, a Tempus Company, at the US Oncology Network Hereditary Genetics & Precision Medicine Conference to explore the early stages of our collaboration and the latest in AI-driven precision medicine. Learn about our precision medicine solutions, discover key differentiators, and see how we are advancing hereditary genetics and personalized care together.